Adham N - Search Results

1

Hartig PR, Adham N, Zgombick J, Macchi M, Kao HT, Schechter L, Branchek T, Weinshank R. Hartig PR, et al. Among authors: adham n. Psychopharmacol Ser. 1993;10:15-25. doi: 10.1007/978-3-642-78010-3_3. Psychopharmacol Ser. 1993. PMID: 8361973 Review. No abstract available.

2

Site-directed mutagenesis of a single residue changes the binding properties of the serotonin 5-HT2 receptor from a human to a rat pharmacology.

Kao HT, Adham N, Olsen MA, Weinshank RL, Branchek TA, Hartig PR. Kao HT, et al. Among authors: adham n. FEBS Lett. 1992 Aug 3;307(3):324-8. doi: 10.1016/0014-5793(92)80705-l. FEBS Lett. 1992. PMID: 1644189 Free article.

3

The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.

Adham N, Romanienko P, Hartig P, Weinshank RL, Branchek T. Adham N, et al. Mol Pharmacol. 1992 Jan;41(1):1-7. Mol Pharmacol. 1992. PMID: 1732716

4

The molecular biology of serotonin receptors. An overview.

Hartig P, Kao HT, Macchi M, Adham N, Zgombick J, Weinshank R, Branchek T. Hartig P, et al. Among authors: adham n. Neuropsychopharmacology. 1990 Oct-Dec;3(5-6):335-47. Neuropsychopharmacology. 1990. PMID: 2078270 Review.

5

[3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.

Branchek T, Adham N, Macchi M, Kao HT, Hartig PR. Branchek T, et al. Among authors: adham n. Mol Pharmacol. 1990 Nov;38(5):604-9. Mol Pharmacol. 1990. PMID: 2233697

6

The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, Bard JA, Vaysse PJ, Hartig PR, Branchek TA, et al. Gerald C, et al. Among authors: adham n. EMBO J. 1995 Jun 15;14(12):2806-15. doi: 10.1002/j.1460-2075.1995.tb07280.x. EMBO J. 1995. PMID: 7796807 Free PMC article.

7

Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.

Adham N, Ellerbrock B, Hartig P, Weinshank RL, Branchek T. Adham N, et al. Mol Pharmacol. 1993 Mar;43(3):427-33. Mol Pharmacol. 1993. PMID: 8095694

8

Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.

Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL. Bard JA, et al. Among authors: adham n. J Biol Chem. 1993 Nov 5;268(31):23422-6. J Biol Chem. 1993. PMID: 8226867 Free article.

9

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.

Adham N, Kao HT, Schecter LE, Bard J, Olsen M, Urquhart D, Durkin M, Hartig PR, Weinshank RL, Branchek TA. Adham N, et al. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):408-12. doi: 10.1073/pnas.90.2.408. Proc Natl Acad Sci U S A. 1993. PMID: 8380639 Free PMC article.

10

Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.

Zgombick JM, Schechter LE, Adham N, Kucharewicz SA, Weinshank RL, Branchek TA. Zgombick JM, et al. Among authors: adham n. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):226-36. doi: 10.1007/BF00171052. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8878051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page